These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1516563)

  • 1. Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade.
    Gordon MS; Williams GH; Hollenberg NK
    Endocr Res; 1992; 18(2):115-31. PubMed ID: 1516563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.
    Taylor T; Moore TJ; Hollenberg NK; Williams GH
    Hypertension; 1984; 6(1):92-9. PubMed ID: 6198274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
    Arafah BM; Gordon NH; Salazar R; Douglas JG
    J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK; Fisher ND; Price DA; Williams GH
    Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid modulation of renal and adrenal responsiveness to angiotensin II.
    Conlin PR; Moore TJ; Williams GH; Hollenberg NK
    Hypertension; 1993 Dec; 22(6):832-8. PubMed ID: 7503952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
    Oda H; Lotshaw DP; Franco-Saenz R; Mulrow PJ
    Proc Soc Exp Biol Med; 1991 Feb; 196(2):175-7. PubMed ID: 1846675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of angiotensin II receptors in vascular regulation.
    Catt KJ; Mendelsohn FA; Millan MA; Aguilera G
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S575-86. PubMed ID: 6083400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the adrenal and renal responses to angiotensin II fetal lambs and adult sheep.
    Robillard JE; Gomez RA; VanOrden D; Smith FG
    Circ Res; 1982 Jan; 50(1):140-7. PubMed ID: 7032744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.